当前位置: 首页 > 期刊 > 《医学信息》 > 2025年第13期
编号:2390305
益气化痰方联合化疗对肺癌患者毒副反应及生存质量的影响
http://www.100md.com 2025年7月31日 医学信息 2025年第13期
     中图分类号:R734.2文献标识码:A

    DOI:10.3969/j.issn.1006-1959.2025.13.032 文章编号:1006-1959(2025)13-0158-04

    Abstract:ObjetiveTostudythefectsofYiqiHuatanforulacombinedwithchemotherapyonthetoxicityandquaityoflifeinpatintsit lungcancer.MetodsAtotalof86patientsihngcanerdiagodintheDepartmentofRespiratoryandCritialCareMedicineofGangfen DistrictPeople'sHospitalfroJauary1toDcember3eredividedintohemotheraoup(43patints)ndcombindgou(3patints) byrandomnumbertabletodTechemotherapygoupeceivedroutinechemotherapyandthecombinedgroupastreatedwithYiqiuatan foulaothifuiaitfeca CancerTerapy-Lungcale(FACT-L)QualityofLifeQuestioareCore3O(LQ-C30)werecomparedbetweenthetwogroupsResultse disease control rate of the combined group was higher than that of the chemotherapy group( Plt;0.05 .After treatment,the scores of TCMsymptoms (coughandepotiotigsdstseatdsiotosesdd symptoms(oudxpecoatoesttsdstpinrssofathndak)ibdoeeraoei thechemotherapygroup(P

    Keywords:Lungcancer,Chemotherapy;Yiqi Huatanformula;Toxicity;Qualityoflife;TaditionalChinesemedicinesymptoscore

    肺癌(lungcancer)为我国高发恶性肿瘤类型,具有发病率高、病情进展快、预后差等特点,其早期症状隐匿 ......

您现在查看是摘要页,全文长 10398 字符